Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioblastoma × Capecitabine × Clear all

Phase

Status

Completed 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Rectal Neoplasms 25 Stomach Neoplasms 21 Colorectal Neoplasms 18 Triple Negative Breast Neoplasms 13 Neoplasm Metastasis 9 Nasopharyngeal Carcinoma 8 Colonic Neoplasms 8 Locally Advanced Rectal Cancer 7 Pancreatic Neoplasms 6 Esophageal Neoplasms 6 Biliary Tract Neoplasms 6 Brain Neoplasms 5 Adenocarcinoma Of Esophagus 5 Neuroendocrine Tumors 3 Neoplasms 3 Cholangiocarcinoma 3 Anus Neoplasms 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm, Residual 2 Meningeal Neoplasms 2 HER2-positive Breast Cancer 2 Gastrointestinal Neoplasms 2 Early Low Rectal Cancer 2 Colorectal Cancer Metastatic 2 Carcinoma 2

Interventions

Temozolomide 40 Radiotherapy 18 Magnetic Resonance Spectroscopy 12 pembrolizumab 11 Specimen Handling 10 Lomustine 10 Bevacizumab 10 Radiation 7 Cyclophosphamide 5 fludarabine 4 Nivolumab 4 Aminolevulinic Acid 4 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Ipilimumab 3 regorafenib 2 olaparib 2 fluciclovine F-18 2 atezolizumab 2 antisecretory factor 2 abemaciclib 2 Standard of Care 2 Restraint, Physical 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Palliative Care 2 Oncolytic Virotherapy 2 ONC206 2 Metformin 2 Leukapheresis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03213002 2025-04-09

CAPTEM

Northwell Health

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡